From amphetamines to slimming pills, there is a long history of weight-loss drug crazes that ended in disappointment, or worse. Until anti-obesity medicines such as Wegovy and Zepbound, none of them had started out promisingly and then produced better and broader results.It is surprising, but studies of the health impact of the new generation of weight drugs have steadily brought more encouraging news. One published this week found that patients who took Novo Nordisk’s Wegovy sustained weight loss for up to four years. It builds on data from last November showing the drug reduced the risks of heart attacks and death.
从安非他明(Amphetamine)到瘦身药丸，人类对减肥药的狂热有着悠久的历史，但每一次都以失望告终，甚至是更糟。在Wegovy和Zepbound这类抗肥胖药物出现之前，没有任何一种药物像它们这样，在开始时令人充满希望，随后居然产生了更好、更广泛的效果。